Total Intravenous Anesthesia
Although TIVA does not necessarily require an opioid component,
especially in minimally stimulating procedures, the fentanyl congeners most often
are an important part of TIVA. Numerous advantages exist when drugs are administered
by infusion.[389]
Many different intravenous compounds can be employed in a number
of combinations to provide TIVA. Most commonly, an opioid is combined with another
drug more likely to provide hypnosis and amnesia. For example, the combination of
alfentanil and propofol produces excellent TIVA. Alfentanil provides analgesia and
hemodynamic stability while blunting responses to noxious stimuli. On the other
hand, propofol provides hypnosis and amnesia and is antiemetic. Profound synergism
also exists when more than two agents, such as propofol-alfentanil-midazolam, are
combined.[390]
[391]
Anesthetic induction with alfentanil (25–50 µg/kg) and propofol (0.5–1.5
mg/kg) followed by infusions of 0.5–1.5 µg/kg/min of alfentanil and 80–120
µg/kg/minute of propofol will produce complete anesthesia in patients ventilated
with air and O2
with or without N2
O for a variety of procedures.
It is proposed that alfentanil concentrations as low as 85 ng/mL, when combined
with a blood propofol concentration of 3.5 µg/mL, can produce both optimal
anesthetic conditions and speed of recovery.[391]
Stanski and Shafer suggested that bolus doses and initial infusion rates would be
30 µg/kg and 0.35 µg/kg/minute, respectively, for alfentanil and 0.7
mg/kg and 180 µg/kg/minute, respectively, for propofol.[392]
Recognizing that these calculations were
based on EC50
data in patients undergoing only moderately painful procedures,
anesthesiologists should adjust these doses accordingly. Premedication prior to
alfentanil-propofol anesthesia can prolong postoperative recovery and should be avoided
if appropriate.[393]
In patients undergoing ear-nose-throat
surgery, TIVA with remifentanil and propofol provided a more rapid respiratory recovery
after brief surgical procedures, compared with TIVA with alfentanil and propofol.
[394]
The optimal propofol-opioid concentrations that ensure adequate
anesthesia and rapid emergence were determined by computer modeling.[327]
The optimal propofol concentration decreases in the order of fentanyl > alfentanil
> sufentanil ≫ remifentanil. A shorter context-sensitive half-time allows
the administration of greater amounts of opioid (and less propofol) during anesthesia
without creating prolonged opioid effects.
Maintenance infusions vary according to patient condition and
surgical stimuli. Propofol (75–125 µg/kg/minute) and alfentanil (1.0–2.0
µg/kg/minute) are initially recommended. Drug infusions should be terminated
10 to 20 minutes prior to end of anesthesia if N2
O is employed. Otherwise,
propofol infusions should be terminated 5 to 10 minutes before anticipated patient
awakening. Alfentanil infusion rates do not need to be less than 0.25–0.5
µg/kg/minute until surgery is terminated. A multicenter evaluation demonstrated
that in patients during elective surgery, remifentanil (1 µg/kg IV followed
by 1.0 µg/kg/minute) when combined with propofol (75 µg/kg/minute) effectively
controlled responses to tracheal intubation.[381]
Remifentanil infusion rate of 0.25 µg/kg/minute after tracheal intubation
was also recommended.
Midazolam-opioid combinations can also provide complete anesthesia.
However, midazolam-alfentanil TIVA has not been found to compare favorably to propofol-alfentanil
TIVA even with flumazenil reversal of benzodiazepine actions.[395]
However, TIVA for major (cardiac) and/or long operations may be effectively achieved
with the combination of midazolam and sufentanil.[396]
TIVA techniques are especially useful when delivery of inhaled
agents is compromised. By keeping the goals of balanced anesthesia in mind, combining
modern opioids and other drugs, utilizing infusion pumps, and employing an increased
understanding of pharmacokinetics, clinicians can successfully perform a wide variety
of TIVA techniques. Approximate opioid doses and infusion rates for TIVA are listed
in Table 11-9
.